Literature DB >> 18400416

Nutrition and breast cancer among sporadic cases and gene mutation carriers: an overview.

Vishnee Bissonauth1, Bryna Shatenstein, Parviz Ghadirian.   

Abstract

BACKGROUND: Breast cancer is the second leading cause of cancer-related deaths among women in most industrialized countries. Most breast cancers are considered sporadic, with only 5-10% estimated to be due to inherited susceptibility. The objective of this paper is to provide an overview of the effect of nutrition on breast cancer risk among gene mutation carriers as well as those with sporadic breast cancer.
METHODS: The published literature from 1999 to 2007 was reviewed to examine the relationship between nutrition and breast cancer among sporadic cases and gene mutation carriers.
RESULTS: Evidence suggests that fruits and vegetables, low-fat dairy products, fish, monounsaturated and polyunsaturated fatty acids, vitamin D, calcium, and phytoestrogens may reduce the risk of breast cancer. However, high intake of meat, poultry, total energy, total fat and saturated fatty acids may play a causative role in this disease.
CONCLUSIONS: Diet in breast cancer pathogenesis is a modifiable risk factor on which to focus prevention efforts. Identification of the relationship between nutrition and breast cancer among sporadic cases and gene mutation carriers provides necessary data for breast cancer prevention.

Entities:  

Mesh:

Year:  2008        PMID: 18400416     DOI: 10.1016/j.cdp.2008.01.005

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  6 in total

1.  Fatty acid intake and breast cancer in the Spanish multicase-control study on cancer (MCC-Spain).

Authors:  Trinidad Dierssen-Sotos; Inés Gómez-Acebo; Camilo Palazuelos; Esther Gracia-Lavedan; Beatriz Pérez-Gómez; Madalen Oribe; Vicente Martín; Marcela Guevara; Paz Rodríguez-Cundín; Guillermo Fernández-Tardón; Rafael Marcos-Gragera; Ana Molina-Barceló; Marian Díaz-Santos; Gemma Castaño-Vinyals; Nuria Aragonés; Ana López-Gonzalez; Pilar Amiano; Jesús Castilla; Jessica Alonso-Molero; Manolis Kogevinas; Marina Pollán; Javier Llorca
Journal:  Eur J Nutr       Date:  2019-05-08       Impact factor: 5.614

Review 2.  Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective.

Authors:  Keneuoe Cecilia Nthontho; Andrew Khulekani Ndlovu; Kirthana Sharma; Ishmael Kasvosve; Daniel Louis Hertz; Giacomo Maria Paganotti
Journal:  Pharmgenomics Pers Med       Date:  2022-06-21

3.  Breast cancer in the personal genomics era.

Authors:  Rachel E Ellsworth; David J Decewicz; Craig D Shriver; Darrell L Ellsworth
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

4.  Evaluation of Methylation Status in the 5'UTR Promoter Region of the DBC2 Gene as a Biomarker in Sporadic Breast Cancer.

Authors:  Mehri Hajikhan Mirzaei; Mehrdad Noruzinia; Hamid Karbassian; Yousef Shafeghati; Mousa Keyhanee; Ali Bidmeshki-Pour
Journal:  Cell J       Date:  2012-06-13       Impact factor: 2.479

Review 5.  Nutrigenomics and Breast Cancer: State-of-Art, Future Perspectives and Insights for Prevention.

Authors:  Maha Sellami; Nicola Luigi Bragazzi
Journal:  Nutrients       Date:  2020-02-18       Impact factor: 5.717

6.  Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.

Authors:  J Wen; R Li; Y Lu; M A Shupnik
Journal:  Oncogene       Date:  2008-11-10       Impact factor: 9.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.